Jieming Qu
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- COVID-19 Clinical Research Studies 14
- SARS-CoV-2 and COVID-19 Research 12
- Antifungal resistance and susceptibility 6
-
- Neonatal Respiratory Health Research 11
- Co-authors
- Yinggang Zhu (16 shared papers)Xinxin Zhang (4 shared papers)Min Zhou (4 shared papers)Antoine Monsel (7 shared papers)Jing Zhang (15 shared papers)Michael A. Matthay (1 shared paper)Xiaomei Feng (1 shared paper)Xiaohui Fang (1 shared paper)
- Journals
- Inflammation Research (5 papers)Respiratory Research (4 papers)Nature Communications (4 papers)Acta Pharmacologica Sinica (4 papers)Frontiers in Microbiology (3 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Jieming Qu
129 papers receiving 7.1k citations
Jieming Qu's Hit Papers
Peers
Comparison fields: 5 of 158
- Infectious Diseases 2.6k
- Molecular Medicine 374
- Neurology 841
- Genetics 552
- Applied Microbiology and Biotechnology 65
Countries citing papers authored by Jieming Qu
This map shows the geographic impact of Jieming Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieming Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieming Qu more than expected).
Fields of papers citing papers by Jieming Qu
This network shows the impact of papers produced by Jieming Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieming Qu. The network helps show where Jieming Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jieming Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effectiveness of convalescent plasma therapy in severe COVID-19 patients Hit paper breakdown → | 2020 | 1452 |
| 2 | Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial Hit paper breakdown → | 2020 | 755 |
| 3 | Human Mesenchymal Stem Cell Microvesicles for Treatment of Escherichia coli Endotoxin-Induced Acute Lung Injury in Mice Hit paper breakdown → | 2013 | 568 |
| 4 | 2020 | 340 | |
| 5 | 2017 | 219 | |
| 6 | 2008 | 202 | |
| 7 | 2017 | 200 | |
| 8 | 2021 | 183 | |
| 9 | 2006 | 179 | |
| 10 | 2021 | 166 | |
| 11 | 2017 | 151 | |
| 12 | Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study Hit paper breakdown → | 2022 | 150 |
| 13 | 2013 | 136 | |
| 14 | 2020 | 132 | |
| 15 | 2021 | 112 | |
| 16 | 2020 | 106 | |
| 17 | 2023 | 101 | |
| 18 | 2019 | 100 | |
| 19 | 2020 | 89 | |
| 20 | 2023 | 76 |
About Jieming Qu
Jieming Qu is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Molecular Medicine, Immunology and Genetics, having authored 135 papers that have together received 7.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (14 papers), SARS-CoV-2 and COVID-19 Research (12 papers), Neonatal Respiratory Health Research (11 papers), Antibiotic Resistance in Bacteria (10 papers), Immune Response and Inflammation (8 papers), Mesenchymal stem cell research (7 papers), Extracellular vesicles in disease (6 papers) and Antifungal resistance and susceptibility (6 papers). The work is most often cited by research in Infectious Diseases (2.6k citations), Molecular Medicine (374 citations), Neurology (841 citations), Genetics (552 citations) and Applied Microbiology and Biotechnology (65 citations). Jieming Qu has collaborated with scholars based in China, United States and France. Frequent co-authors include Yinggang Zhu, Xinxin Zhang, Min Zhou, Antoine Monsel, Jing Zhang, Michael A. Matthay, Xiaomei Feng, Xiaohui Fang, Jae Woo Lee and Hao Qi. Their work appears in journals such as Inflammation Research, Respiratory Research, Nature Communications, Acta Pharmacologica Sinica and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.